This groundbreaking multicenter gene therapy study, published in Nature, investigated the long-term effects of OTOF gene therapy for OTOF-related deafness, with follow-up extending up to 2.5 years. The research focuses on the efficacy and safety of this novel treatment approach for a specific genetic cause of hearing loss. The findings of this study are highly significant for clinicians treating individuals with OTOF-related deafness. While the abstract doesn't detail specific clinical recommendations or the direct involvement of SLPs, the extended follow-up period offers crucial insights into the sustained impact of gene therapy on hearing outcomes. This research paves the way for understanding the potential of genetic interventions in restoring auditory function.
Original publication date: 2026 Apr 22
Read Full Research Article →